DMK Pharmaceuticals Corporation Common Stock
DMK was delisted on the 6th of February, 2024.
35 hedge funds and large institutions have $8.88M invested in DMK Pharmaceuticals Corporation Common Stock in 2016 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 11 closing their positions.
100% more repeat investments, than reductions
Existing positions increased: 10 | Existing positions reduced: 5
5% less funds holding
Funds holding: 37 → 35 (-2)
11% less capital invested
Capital invested by funds: $9.99M → $8.88M (-$1.11M)
18% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 11
66% less call options, than puts
Call options by funds: $117K | Put options by funds: $342K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Sio Capital Management
New York
|
+$1.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$388K |
| 3 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$178K |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$60.8K |
| 5 |
SGS
Sterling Global Strategies
Carlsbad,
California
|
+$54.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Walleye Trading
New York
|
-$880K |
| 2 |
PVI
Pura Vida Investments
New York
|
-$875K |
| 3 |
MSU
Mizuho Securities USA
New York
|
-$454K |
| 4 |
VKH
Virtu KCG Holdings
New York
|
-$315K |
| 5 |
Millennium Management
New York
|
-$83K |
DMK Hedge Fund Activity: Q4 2016 in Review
35 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in DMK Pharmaceuticals Corporation Common Stock (DMK) for Q4 2016, worth a combined $8.88M — down 11% from $9.99M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of DMK and 9 opened new positions — a net loss of 2 holders — while 5 trimmed existing stakes and 10 added.
The largest buyer was Sio Capital Management, adding an estimated $1.1M. The largest seller was Walleye Trading, exiting entirely with an estimated $880K sold.
- 35 institutional investors held DMK Pharmaceuticals Corporation Common Stock (DMK) as of Q4 2016, down from 37 in Q3 2016.
- Funds reported $8.88M of DMK Pharmaceuticals Corporation Common Stock stock for Q4 2016, down 11% quarter-over-quarter.
- 9 funds opened new DMK Pharmaceuticals Corporation Common Stock positions in Q4 2016 and 11 closed out, a net change of -2 holders.
- The largest DMK Pharmaceuticals Corporation Common Stock buyer in Q4 2016 was Sio Capital Management, an estimated $1.1M added.
- The largest DMK Pharmaceuticals Corporation Common Stock seller in Q4 2016 was Walleye Trading, an estimated $880K sold.
Based on aggregated 13F filings for Q4 2016.